Clinical significance of pharmacological modulation of homocysteine metabolism
- 31 October 1990
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 11 (10) , 411-416
- https://doi.org/10.1016/0165-6147(90)90148-2
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Azarbine-homocystinemia-thrombosis in historical perspectivePharmacology & Therapeutics, 1989
- IS ABSENCE OF ATHEROMA IN DOWN SYNDROME DUE TO DECREASED HOMOCYSTEINE LEVELS?The Lancet, 1988
- Adjuvant Therapy for Breast CancerNew England Journal of Medicine, 1988
- Effect of methotrexate on intracellular folate pools in purified myeloid precursor cells from normal human bone marrow.Journal of Clinical Investigation, 1987
- Metabolism of the diaminoantifolates: Biosynthesis and pharmacology of the 7-hydroxyl and polyglutamyl metabolites of methotrexate and related antifolatesPharmacology & Therapeutics, 1987
- Protein‐Bound Homocyst(e)ine in Patients With Rheumatoid Arthritis Undergoing D‐Penicillamine TreatmentThe Journal of Clinical Pharmacology, 1986
- Methotrexate Therapy in Rheumatoid Arthritis Current StatusDrugs, 1986
- Drugs and Folate MetabolismDrugs, 1985
- Decreased methionine synthesis in purine nucleoside-treated T and B lymphoblasts and reversal by homocysteine.Journal of Clinical Investigation, 1984
- Down's syndrome: an atheroma-free model?BMJ, 1977